Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShawbrook Group Regulatory News (SHAW)

Share Price Information for Shawbrook Group (SHAW)

Share Price is delayed by 15 minutes
Get Live Data
306.00    1.00 (0.33%)
Bid:
306.00
Ask:
308.50
Spread: 2.50 (0.817%)
Market Cap: £1.59b
SHAW Live PriceLast checked at - London Stock Exchange

Intraday Shawbrook Group Share Chart

Shawbrook Group plc Post-Stabilisation Notice

28 Nov 2025 17:14

RNS Number : 5211J
Barclays Bank PLC
28 November 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL. 

28 November 2025

Shawbrook Group plcPost-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 30 October 2025, Barclays Capital Securities Limited (Contact: Ben Newmark; Telephone: +44 20 3134 8574) hereby gives notice that the Stabilising Manager named below and its affiliates undertook stabilisation in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 of the European Parliament and of the Council (as it forms part of retained EU law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018).

 The securities

Issuer

Shawbrook Group plc

Securities

Ordinary Shares of £0.005 pence each

ISIN

GB00BV9DPV21

Offering Size

94,007,050 Ordinary Shares (excluding the over-allotment option)

Description

Initial Public Offering of Ordinary Shares

Offer price

370 pence per Ordinary Share

Stabilising Manager

Barclays Capital Securities Limited, 1 Churchill Place, London, E14 5HP, United Kingdom

Stabilisation period

From 30 October 2025 to 28 November 2025

Stabilisation last occurred on

24 November 2025

Stabilisation trading venue(s)

London Stock Exchange

Stabilisation transactions

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Execution Date

Lowest Price

Highest Price

Trading Venue

5 November 2025

370.00

370.00

London Stock Exchange

6 November 2025

370.00

370.00

London Stock Exchange

18 November 2025

370.00

370.00

London Stock Exchange

19 November 2025

370.00

370.00

London Stock Exchange

20 November 2025

369.00

370.00

London Stock Exchange

21 November 2025

366.00

366.00

London Stock Exchange

24 November 2025

366.00

366.00

London Stock Exchange

Barclays Capital Securities Limited, acting as the stabilising manager, has today given notice to exercise the over-allotment option (the "Over-allotment Option") granted by Marlin Bidco Limited in respect of 13,673,547 ordinary shares in Shawbrook at the offer price of 370 pence per share.

Giving effect to the exercise of the Over-allotment Option, the final size of the Offer is approximately £398 million (approximately 108 million ordinary shares), representing approximately 21 per cent. of the ordinary shares in Shawbrook.

 

Important legal information

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons").

In any member state of the European Economic Area ("EEA") (each, a "Relevant Member State"), this announcement and any offer if made subsequently is, and will be, directed only at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129).

This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 as amended (the "Securities Act") and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFEEFWAEISEFF
Date   Source Headline
21st May 20264:12 pmRNSResult of AGM
21st May 20261:41 pmRNSResidential Mortgage-Backed Securities May 2026
14th May 20267:00 amRNSShawbrook Q1 2026 Trading Update
6th May 202610:29 amRNSTender Offer Results Announcement
5th May 20266:24 pmRNSRecent media coverage
28th Apr 20264:52 pmRNSSuccessful Pricing of £250 million AT1 Securities
27th Apr 20269:16 amRNSTender Offer Announcement - AT1 Securities
24th Apr 20264:04 pmRNSNotice of AGM
24th Apr 202612:41 pmRNSHolding(s) in Company
20th Apr 20263:10 pmRNSDirector/PDMR Shareholding
9th Apr 20264:25 pmRNSHolding(s) in Company
9th Apr 20264:19 pmRNSDirector/PDMR Shareholding
25th Mar 20262:52 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
19th Feb 20265:00 pmRNSAppointment of Joint Corporate Brokers
14th Jan 20265:00 pmRNSDirector/PDMR Shareholding
8th Jan 20265:07 pmRNSDirector/PDMR Shareholding
16th Dec 20255:00 pmRNSDirector/PDMR Shareholding
4th Dec 20255:00 pmRNSResidential Mortgage-Backed Securities December 25
4th Dec 20257:00 amRNSInclusion in the FTSE 250 Index
28th Nov 20255:14 pmRNSShawbrook Group plc Post-Stabilisation Notice
28th Nov 20255:09 pmRNSExercise of Over-allotment Option
24th Nov 20255:27 pmRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Q3 2025 Trading Update
4th Nov 20251:16 pmRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSAdmission to trading on the London Stock Exchange
30th Oct 20257:00 amRNSAnnouncement of Pricing and Offer Size
9th Aug 20179:13 amRNSAdditional Listing
1st Aug 20173:49 pmRNSDate of cancellation of listing
1st Aug 20173:43 pmRNSTR-1 - Notification of Major Interest in Shares
27th Jul 201710:40 amRNSExercise of Options and Acceptance of Offer
26th Jul 201712:04 pmRNSExercise of Options and Acceptance of Offer
25th Jul 20173:31 pmRNSExercise of Options and Acceptance of Offer
19th Jul 20173:42 pmRNSCompulsory acquisition of Shawbrook shares
12th Jul 20175:00 pmRNSUpdate on Final Offer and Compulsory Acquisition
11th Jul 201711:30 amRNSPDMR Dealing - Amendment and Initial Notification
10th Jul 20172:58 pmRNSPDMR Dealing - Acceptance of the Offer
7th Jul 20176:16 pmRNSFinal offer declared unconditional in all respects
5th Jul 201711:05 amRNSNotification of Transactions of a PDMR
30th Jun 201710:27 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 201710:19 amRNSTR-1: Notification of Major Interest in Shares
23rd Jun 201710:58 amRNSTR-1 - Notification of Major Interest in Shares
23rd Jun 20179:00 amRNSNotification of Transactions of PDMR
21st Jun 20175:42 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 20173:20 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 201711:43 amRNSForm 8.5 (EPT/RI)
20th Jun 201711:22 amRNSForm 8.5 (EPT/RI)
20th Jun 20179:36 amRNSForm 8.5 (EPT/RI) - Shawbrook Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.